Title: p38a MAPK is involved in BMP-2-induced odontoblastic differentiation of human dental pulp cells.
Journal: International endodontic journal 20120301
Title: From benzimidazole to indole-5-carboxamide Thumb Pocket I inhibitors of HCV NS5B polymerase. Part 1: indole C-2 SAR and discovery of diamide derivatives with nanomolar potency in cell-based subgenomic replicons.
Journal: Bioorganic & medicinal chemistry letters 20110615
Title: Indole 5-carboxamide Thumb Pocket I inhibitors of HCV NS5B polymerase with nanomolar potency in cell-based subgenomic replicons (part 2): central amino acid linker and right-hand-side SAR studies.
Journal: Bioorganic & medicinal chemistry letters 20110615
Title: Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication.
Journal: Experimental parasitology 20110601
Title: P38alpha-selective mitogen-activated protein kinase inhibitor for improvement of cultured human islet recovery.
Journal: Pancreas 20100501
Title: Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma.
Journal: The European respiratory journal 20100401
Title: 3D-QSAR studies of arylcarboxamides with inhibitory activity on InhA using pharmacophore-based alignment.
Journal: Chemical biology & drug design 20100201
Title: Topical alpha-selective p38 MAP kinase inhibition reduces acute skin inflammation in guinea pig.
Journal: Journal of inflammation research 20100101
Title: p38 Mitogen-activated protein kinase inhibition reduces inflammatory cytokines in a brain-dead transplant donor animal model.
Journal: Heart, lung & circulation 20091201
Title: Spinal p38 mitogen-activated protein kinase mediates allodynia induced by first-degree burn in the rat.
Journal: Journal of neuroscience research 20090301
Title: p38 MAPK inhibition reduces diabetes-induced impairment of wound healing.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy 20090101
Title: Role of p38 mitogen-activated protein kinase in ozone-induced airway hyperresponsiveness and inflammation.
Journal: European journal of pharmacology 20081214
Title: Prevention of trabecular bone loss induced by estrogen deficiency by a selective p38alpha inhibitor.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20080901
Title: p38alpha-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation.
Journal: The Journal of pharmacology and experimental therapeutics 20080301
Title: Pharmacological properties of SD-282 - an alpha-isoform selective inhibitor for p38 MAP kinase.
Journal: Pharmacology 20080101
Title: A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model.
Journal: Journal of periodontology 20071001
Title: Improvement of human islet cryopreservation by a p38 MAPK inhibitor.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20070501
Title: Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.
Journal: Cancer research 20070501
Title: A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss.
Journal: The Journal of pharmacology and experimental therapeutics 20070101
Title: Selective inhibition of p38alpha MAPK improves cardiac function and reduces myocardial apoptosis in rat model of myocardial injury.
Journal: American journal of physiology. Heart and circulatory physiology 20061001
Title: Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages.
Journal: British journal of pharmacology 20061001
Title: Importance of p38 mitogen-activated protein kinase pathway in allergic airway remodelling and bronchial hyperresponsiveness.
Journal: European journal of pharmacology 20060821
Title: A selective p38 alpha mitogen-activated protein kinase inhibitor reverses cartilage and bone destruction in mice with collagen-induced arthritis.
Journal: The Journal of pharmacology and experimental therapeutics 20060701
Title: Preventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetes.
Journal: The Journal of pharmacology and experimental therapeutics 20060701
Title: Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses.
Journal: Cancer research 20060701
Title: Peripheral and central p38 MAPK mediates capsaicin-induced hyperalgesia.
Journal: Pain 20041001
Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
Journal: The Journal of biological chemistry 20020419
Title: Potent nonpeptide GnRH receptor antagonists derived from substituted indole-5-carboxamides and -acetamides bearing a pyridine side-chain terminus.
Journal: Bioorganic & medicinal chemistry letters 20010709
Title: Medicherla S, et al. Preventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetes. J Pharmacol Exp Ther. 2006 Jul;318(1):99-107.
